Literature DB >> 29863912

Cardiac metabolic effects of KNa1.2 channel deletion and evidence for its mitochondrial localization.

Charles O Smith1, Yves T Wang2, Sergiy M Nadtochiy2, James H Miller2, Elizabeth A Jonas3, Robert T Dirksen4, Keith Nehrke4,5, Paul S Brookes2,4.   

Abstract

Controversy surrounds the molecular identity of mitochondrial K+ channels that are important for protection against cardiac ischemia-reperfusion injury. Although KNa1.2 (sodium-activated potassium channel encoded by Kcn2) is necessary for cardioprotection by volatile anesthetics, electrophysiological evidence for a channel of this type in mitochondria is lacking. The endogenous physiological role of a potential mito-KNa1.2 channel is also unclear. In this study, single channel patch-clamp of 27 independent cardiac mitochondrial inner membrane (mitoplast) preparations from wild-type (WT) mice yielded 6 channels matching the known ion sensitivity, ion selectivity, pharmacology, and conductance properties of KNa1.2 (slope conductance, 138 ± 1 pS). However, similar experiments on 40 preparations from Kcnt2-/- mice yielded no such channels. The KNa opener bithionol uncoupled respiration in WT but not Kcnt2-/- cardiomyocytes. Furthermore, when oxidizing only fat as substrate, Kcnt2-/- cardiomyocytes and hearts were less responsive to increases in energetic demand. Kcnt2-/- mice also had elevated body fat, but no baseline differences in the cardiac metabolome. These data support the existence of a cardiac mitochondrial KNa1.2 channel, and a role for cardiac KNa1.2 in regulating metabolism under conditions of high energetic demand.-Smith, C. O., Wang, Y. T., Nadtochiy, S. M., Miller, J. H., Jonas, E. A., Dirksen, R. T., Nehrke, K., Brookes, P. S. Cardiac metabolic effects of KNa1.2 channel deletion and evidence for its mitochondrial localization.

Entities:  

Keywords:  Slick; Slo2.1; bithionol; patch clamp

Year:  2018        PMID: 29863912      PMCID: PMC6181635          DOI: 10.1096/fj.201800139R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  64 in total

1.  Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line.

Authors:  D Siemen; C Loupatatzis; J Borecky; E Gulbins; F Lang
Journal:  Biochem Biophys Res Commun       Date:  1999-04-13       Impact factor: 3.575

2.  Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits.

Authors:  W J Joiner; M D Tang; L Y Wang; S I Dworetzky; C G Boissard; L Gan; V K Gribkoff; L K Kaczmarek
Journal:  Nat Neurosci       Date:  1998-10       Impact factor: 24.884

Review 3.  The pathophysiology of mitochondrial cell death.

Authors:  Douglas R Green; Guido Kroemer
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 4.  Mitochondrial dysfunction in cardiac disease: ischemia--reperfusion, aging, and heart failure.

Authors:  E J Lesnefsky; S Moghaddas; B Tandler; J Kerner; C L Hoppel
Journal:  J Mol Cell Cardiol       Date:  2001-06       Impact factor: 5.000

5.  Pharmacological activation and inhibition of Slack (Slo2.2) channels.

Authors:  Bo Yang; Valentin K Gribkoff; Jennifer Pan; Veronique Damagnez; Steven I Dworetzky; Christopher G Boissard; Arin Bhattacharjee; Yangyang Yan; Fred J Sigworth; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2006-07-28       Impact factor: 5.250

6.  Effects of 2,3-butanedione 2-monoxime on Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.

Authors:  A Tripathy; L Xu; D A Pasek; G Meissner
Journal:  J Membr Biol       Date:  1999-06-01       Impact factor: 1.843

7.  Inhibitory effect of 2,3-butanedione monoxime (BDM) on Na(+)/Ca(2+) exchange current in guinea-pig cardiac ventricular myocytes.

Authors:  Y Watanabe; T Iwamoto; I Matsuoka; S Ohkubo; T Ono; T Watano; M Shigekawa; J Kimura
Journal:  Br J Pharmacol       Date:  2001-03       Impact factor: 8.739

8.  Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease.

Authors:  Varman T Samuel; Zhen-Xiang Liu; Amy Wang; Sara A Beddow; John G Geisler; Mario Kahn; Xian-man Zhang; Brett P Monia; Sanjay Bhanot; Gerald I Shulman
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

9.  Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel inhibited by ATP.

Authors:  Arin Bhattacharjee; William J Joiner; Meilin Wu; Youshan Yang; Fred J Sigworth; Leonard K Kaczmarek
Journal:  J Neurosci       Date:  2003-12-17       Impact factor: 6.167

10.  Quantitative analysis of spontaneous mitochondrial depolarizations.

Authors:  Catherine M O'Reilly; Kevin E Fogarty; Robert M Drummond; Richard A Tuft; John V Walsh
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

View more
  10 in total

1.  Lactate Dehydrogenase Inhibition With Oxamate Exerts Bone Anabolic Effect.

Authors:  Alex M Hollenberg; Charles O Smith; Laura C Shum; Hani Awad; Roman A Eliseev
Journal:  J Bone Miner Res       Date:  2020-09-19       Impact factor: 6.741

Review 2.  Pharmacological modulation of mitochondrial ion channels.

Authors:  Luigi Leanza; Vanessa Checchetto; Lucia Biasutto; Andrea Rossa; Roberto Costa; Magdalena Bachmann; Mario Zoratti; Ildiko Szabo
Journal:  Br J Pharmacol       Date:  2019-01-02       Impact factor: 8.739

Review 3.  Mitochondrial light switches: optogenetic approaches to control metabolism.

Authors:  Brandon J Berry; Andrew P Wojtovich
Journal:  FEBS J       Date:  2020-06-07       Impact factor: 5.542

4.  Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series.

Authors:  Andrew M Griffin; Kristopher M Kahlig; Robert John Hatch; Zoë A Hughes; Mark L Chapman; Brett Antonio; Brian E Marron; Marion Wittmann; Gabriel Martinez-Botella
Journal:  ACS Med Chem Lett       Date:  2021-03-09       Impact factor: 4.345

Review 5.  Recent advances in our understanding of the structure and function of more unusual cation channels.

Authors:  Brandon M Brown; Hai M Nguyen; Heike Wulff
Journal:  F1000Res       Date:  2019-01-30

6.  ALKBH7 mediates necrosis via rewiring of glyoxal metabolism.

Authors:  Chaitanya A Kulkarni; Sergiy M Nadtochiy; Leslie Kennedy; Jimmy Zhang; Sophea Chhim; Hanan Alwaseem; Elizabeth Murphy; Dragony Fu; Paul S Brookes
Journal:  Elife       Date:  2020-08-14       Impact factor: 8.140

Review 7.  Alternative Targets for Modulators of Mitochondrial Potassium Channels.

Authors:  Antoni Wrzosek; Shur Gałecka; Monika Żochowska; Anna Olszewska; Bogusz Kulawiak
Journal:  Molecules       Date:  2022-01-04       Impact factor: 4.411

8.  SLO2.1/NALCN a sodium signaling complex that regulates uterine activity.

Authors:  Juan J Ferreira; Chinwendu Amazu; Lis C Puga-Molina; Xiaofeng Ma; Sarah K England; Celia M Santi
Journal:  iScience       Date:  2021-10-02

Review 9.  Methods of Measuring Mitochondrial Potassium Channels: A Critical Assessment.

Authors:  Agnieszka Walewska; Milena Krajewska; Aleksandra Stefanowska; Aleksandra Buta; Renata Bilewicz; Paweł Krysiński; Piotr Bednarczyk; Piotr Koprowski; Adam Szewczyk
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

Review 10.  The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a Dangerous Liaison in Cancer.

Authors:  Stine F Pedersen; Mette Flinck; Luis A Pardo
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.